“Round up the usual suspects!” This expression, which bespeaks expediency, could apply to the gene editing tools known as cytosine base editors (CBEs). CBEs, which are supposed to convert selected ...
SHANGHAI, Aug. 26, 2025 /PRNewswire/ -- CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for the ...
Figure 1: SaBE3, SaKKH-BE3, VQR-BE3, EQR-BE3, and VRER-BE3 mediate efficient base editing at target sites containing non-NGG PAMs in human cells. To further broaden the targeting range of base editors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results